Trial Profile
A retrospective study assessing serum levels of complement components C3 and in rheumatoid arthritis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 02 Nov 2018 New trial record